SynCore Biotechnology Co.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 1.48 million compared to TWD 3.93 million a year ago. Net loss was TWD 218.65 million compared to TWD 101.99 million a year ago. Basic loss per share from continuing operations was TWD 1.9 compared to TWD 0.96 a year ago. For the nine months, sales was TWD 4.07 million compared to TWD 7.67 million a year ago. Net loss was TWD 378.46 million compared to TWD 296.26 million a year ago. Basic loss per share from continuing operations was TWD 3.34 compared to TWD 2.87 a year ago.